Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Estonia

 

Medicum Group acquires Fertilitas, becomes Estonia’s largest private health fund partner

Medicum Group, an Estonia-based provider of general and specialised medical services backed by pan-Baltic private equity firm Livonia Partners, has acquired AS Fertilitas, a provider of otorhinolaryngology, gynaecology, and surgical care. The combined entity is set to become the largest private contractual partner of the Estonian Health Insurance Fund in specialised medical care, offering diagnostic and treatment services across 18 medical specialties.
April 9, 2026

Estonia plans major hospital consolidation as healthcare system modernisation accelerates

Estonia's Ministry of Social Affairs has unveiled an ambitious plan to consolidate its hospital network through 2040. The proposal centres on merging Tallinn's hospitals into a unified entity, which is likely to require substantial capital investment in new infrastructure. The city, meanwhile, earlier this year, put a new hospital design out to international tender.
December 24, 2024

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

Estonian waiting lists likely to skyrocket in recession

Despite inflation rates of over 20%, Estonia's national health service has not suffered significant ill effects, HBI hears, at least not yet. Looming recession could, however, result in waiting lists as bad as those currently seen in the UK. HBI speaks to a local expert to find out more.
September 22, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022

Clinisys merger creates global player as public labs lag behind in automation

Clinisys claims to have created the world’s largest player in lab information management and lab order comms and results software with a three-way merger which creates a platform across diagnostics and environmental tests. So how does CEO, Michael Simpson, see software changing the sector over the next 3-5 years? And what does an independent consultant with many years experience in the field think about the sector and its growth?
January 27, 2022
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us